When does the Sudeep Pharma IPO open and close?

The Sudeep Pharma IPO opens on 21 Nov and closes on 25 Nov.

Where can I check the live subscription status of the Sudeep Pharma IPO?

You can track the real-time subscription numbers using the links below: https://www.iposcanner.ai/ipo/sudeep-pharma-ipo?tab=subscription

What is the issue size of the Sudeep Pharma IPO?

The size of Sudeep Pharma IPO is Total 1,50,92,750 shares(aggregating up to ₹895 crore) : #Fresh Issue : 16,02,024 shares(aggregating up to ₹95 crore) + #OFS : 1,34,90,726 shares(aggregating up to ₹800 crore).

What is the price band of the Sudeep Pharma IPO?

The Sudeep Pharma IPO price band is set between ₹563-593 per equity share.

What is the minimum investment for the Sudeep Pharma IPO?

The minimum investment for the Sudeep Pharma IPO is ₹14825.

What is the allotment date of the Sudeep Pharma IPO?

The share allotment date of Sudeep Pharma IPO is 26 Nov.

What is the Sudeep Pharma IPO listing date?

The Sudeep Pharma IPO will be listed on 28 Nov.

How to check Sudeep Pharma IPO allotment status online?

Follow the steps to check the Sudeep Pharma IPO allotment status online here: https://www.iposcanner.ai/ipo/sudeep-pharma-ipo?tab=allotment

Who is the registrar for the Sudeep Pharma IPO?

The registrar for the Sudeep Pharma IPO is MUFG Intime India Pvt Ltd. You can check your allotment status on their official website.

IPO ScannerIPO Insights

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO Calendar GMP Tracker Subscription Status Allotment Status

IPOs

All IPOs Live IPOs Upcoming IPOs Closed IPOs Listed IPOs

Resources

eBooks

Company

Home About Us Privacy Policy Terms of Service

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

Want to stay updated?Subscribe to our newsletter

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO Calendar GMP Tracker Subscription Status Allotment Status

IPOs

All IPOs Live IPOs Upcoming IPOs Closed IPOs Listed IPOs

Resources

eBooks

Company

Home About Us Privacy Policy Terms of Service

About IPO Scanner

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Want to stay updated?Subscribe to our newsletter

Sudeep Pharma

Open Date

21 Nov 2025

Close Date

25 Nov 2025

listed

Min Investment

₹14825

Lot Size

25 Shares

Issue Size

₹895 Cr

Price Range

₹563 - ₹593

Listing Date

Nov 28, 2025

About Sudeep Pharma

.read-more-text__content { display: block !important; overflow: visible !important; -webkit-line-clamp: unset !important; -webkit-box-orient: initial !important; } .read-more-text__toggle { display: none !important; }

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.It has six manufacturing facilities that have a combined production capacity of 50,000 MT, manufacturing minerals such as calcium, iron, magnesium, zinc, potassium, and sodium.The company supplies over 200 products to a wide customer base across the pharma, food, and nutrition sectors.The company has strong R&D capabilities comprising in-house labs and pilot-scale facilities for mineral salts and excipients.Product Portfolio:Pharmaceutical, Food and Nutrition BusinessSpecialty Ingredients BusinessTriturates As of 31 December 2024, the company had 704 permanent employees.

Checklist Quality Analysis

Revenue Growth

Live IPOs

Sotefin Bharat

SME

Open Close16th Jul 2026 - 20th Jul 2026

Issue Size89.76 Cr

Min. Qty600 Shares

Issue Price₹ 178.00

Live IPO

Caliber Mining & Logistics

Mainboard

Open Close17th Jul 2026 - 21st Jul 2026

Issue Size450.00 Cr

Min. Qty35 Shares

Issue Price₹ 402.00

Live IPO

Companies Name	Open - Close	Issue Size	Min. Qty	Issue Price	Apply
Sotefin Bharat SME	16th Jul 2026 - 20th Jul 2026	89.76 Cr	600 Shares	₹ 178.00
Caliber Mining & Logistics Mainboard	17th Jul 2026 - 21st Jul 2026	450.00 Cr	35 Shares	₹ 402.00

See All Live IPOs

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

₹112.5(+18.55%)GMP

18.97%Prediction Listing Gain

Grey Market Premium (GMP) Trend

Sudeep Pharma IPO - Issue Objectives

₹75.81 crore will be used for machinery procurement (capex) at the Nandesari Facility. Part of the IPO proceeds will be used for general corporate purposes.

Capital expenditure

79.7%

General corporate purposes

20.3%

Capital expenditure

₹75.81 crore will be used for machinery procurement (capex) at the Nandesari Facility.

79.70%

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes.

20.30%

IPO Subscription Status

QIB

213.08x

NII

116.72x

Individual

15.65x

Total

93.71x

Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).

Financials of Sudeep Pharma

In Cr.

Key Performance Indicator	30-Jun-25 (In Cr.)	31-Mar-25 (In Cr.)	31-Mar-24 (In Cr.)	31-Mar-23 (In Cr.)
Revenue	130.08	511.33	465.38	438.26
EBITDA	48.57	199.28	187.76	98.64
Expenses
Profit After Tax	31.27	138.69	133.15	62.32
Assets	922.26	717.17	513.87	420.11
Net Worth	688.32	497.53	359.07	226.29
Reserves	668.52	481.11	354.59	221.88
Borrowing	135.97	135.25	75.03	82.26

Sudeep Pharma - Promoter(s)

Sudeep Pharma

Sujit Jaysukh Bhayani

Avani Sujit Bhayani

Shanil Sujit Bhayani

Sujeet Jaysukh Bhayani

Pre Issue Share Holding

N/A

Post Issue Share Holding

N/A

About Strength & Risks

Strengths4Risks4

Contact Details

Sudeep Pharma

129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340

+912652840656

[email protected]

https://www.sudeeppharma.com/

Registrar Contact Details

MUFG Intime India Pvt Ltd

+91-22-4918 6270

[email protected]

https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Sudeep Pharma IPO - FAQs

Sudeep Pharma IPO is a Mainboard IPO. The issue is priced at ₹563-593 per equity share. The minimum order quantity is 25 Shares. The IPO opens on 21 Nov, and closes on 25 Nov. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Strong R&D capabilities

With two dedicated R&D centres and a team of 41 specialists, the company has executed 420+ R&D projects over the last 3 years, commercialising 127 products, including Lipoboost (liposomal ingredients) and Novelcap (encapsulated ingredients). R&D spending has scaled to ₹10.04 crore in FY25 and ₹2.67 crore (2.06% of revenue as of June 2025), reflecting sustained focus on formulation enhancement, particle engineering, improved bioavailability, and targeted release.

High exposure to export markets

Exports contributed 58.68% in Q1FY26, 59.27% of revenue in FY25, and 64.43% in FY24 exposing the company to FX volatility, geopolitical risk, and regulatory shifts in overseas markets. The firm's dependency on developed markets like North America (23.19% in FY25) and Europe (9.59%) heightens vulnerability to trade restrictions and tariff changes.

Supply chain concentration and raw material price risk

Raw material costs constitute a significant portion of operations with 46.13% in Q1FY26 and 41.56% of revenue in FY25. Further, top 5 suppliers accounted for 52.02% of total raw material costs in Q1FY26, indicating supplier concentration risk. The absence of long-term supply contracts and dependence on imported inputs (18.57% as of June 2025) make the company vulnerable to supply disruptions and commodity price swings.

Sudeep Pharma

About Sudeep Pharma

Checklist Quality Analysis

Live IPOs

Grey Market Premium (GMP) Trend

Sudeep Pharma IPO - Issue Objectives

Capital expenditure

General corporate purposes

IPO Subscription Status

Financials of Sudeep Pharma

Sudeep Pharma - Promoter(s)

About Strength & Risks

Why this IPO looks interesting

Market leadership and diversified product portfolio

Long-standing global customer base

Well-equipped manufacturing facilities

What investors should watch closely

High customer concentration

Heavy dependence on certain segments

Contact Details

Registrar Contact Details

Sudeep Pharma IPO - FAQs

Strong R&D capabilities

High exposure to export markets

Supply chain concentration and raw material price risk

Sudeep Pharma

About Sudeep Pharma

Checklist Quality Analysis

Live IPOs

Grey Market Premium (GMP) Trend

Sudeep Pharma IPO - Issue Objectives

Capital expenditure

General corporate purposes

IPO Subscription Status

Financials of Sudeep Pharma

Sudeep Pharma - Promoter(s)

About Strength & Risks

Why this IPO looks interesting

Market leadership and diversified product portfolio

Long-standing global customer base

Well-equipped manufacturing facilities

What investors should watch closely

High customer concentration

Heavy dependence on certain segments

Contact Details

Registrar Contact Details

Sudeep Pharma IPO - FAQs

What is Sudeep Pharma IPO?

When does the Sudeep Pharma IPO open and close?

Where can I check the live subscription status of the Sudeep Pharma IPO?

What is the issue size of the Sudeep Pharma IPO?

What is the price band of the Sudeep Pharma IPO?

What is the minimum investment for the Sudeep Pharma IPO?

What is the allotment date of the Sudeep Pharma IPO?

What is the Sudeep Pharma IPO listing date?

How to check Sudeep Pharma IPO allotment status online?

Who is the registrar for the Sudeep Pharma IPO?

Strong R&D capabilities

High exposure to export markets

Supply chain concentration and raw material price risk